Guangzhou Baiy | 600332 - Sales Revenues

Stock Price
23.11
Daily Change
0.35 1.54%
Monthly
-8.18%
Yearly
-12.13%
Q2 Forecast
22.49

Guangzhou Baiy reported CNY16.05B in Sales Revenues for its fiscal quarter ending in December of 2026.





Sales Change Date
Aspen Pharmacare ZAR 17.08B 4.32B Dec/2025
Cipla INR 75.18B 710M Dec/2025
Dr.Reddys Laboratories INR 87.27B 780M Dec/2025
Jiangsu Hengrui CNY 8.44B 1.01B Dec/2025
Kalbe Farma IDR 9.34T 431B Mar/2026
Richter Gedeon HUF 214.69B 26.79B Sep/2025
Sh Fosun Pharma CNY 9.81B 2.35B Mar/2026
Sh Pharmaceutical CNY 73.48B 2.65B Sep/2025
Sun Pharmaceuticals INR 147.99B 3.21B Dec/2025
Teva Pharmaceutical Industries USD 14.63B 10M Dec/2025